Losartan is rarely stopped just because kidney disease is present. In most cases, it should be continued through advanced stages of CKD because it protects the kidneys from further damage. The real reasons to stop or pause losartan are specific lab changes, dangerous potassium levels, or acute illness, not a particular stage of kidney disease on its own.
The 30% Creatinine Rule
After starting losartan or increasing the dose, your creatinine level will often rise slightly. This happens because the drug reduces pressure inside the kidney’s filtering units, which temporarily lowers their output. That dip in filtration is actually part of how losartan protects the kidney long term.
The key number is 30%. A creatinine increase of up to 30% within the first few weeks is considered safe and is actually associated with better kidney preservation over time. Multiple large studies confirm that increases in this range, when they stabilize within about two months, correlate with long-term renal protection regardless of baseline kidney function.
A creatinine rise greater than 30%, however, is a warning sign. It signals that something else may be going on, such as narrowed arteries supplying the kidneys (renal artery stenosis), severe dehydration, or a drop in blood pressure that’s too aggressive. A consistent or severe eGFR drop beyond 30% should prompt your doctor to investigate for underlying vascular disease and consider stopping the medication.
Why Stopping in Advanced CKD Usually Backfires
There’s a longstanding debate about whether losartan and similar drugs should be stopped once kidney function drops very low, around stage 4 or 5 CKD. The concern is that by reducing filtration pressure, the drug might push someone toward dialysis faster. A major clinical trial published in the New England Journal of Medicine in 2022 tested this directly.
The STOP-ACEi trial enrolled 411 patients with advanced, progressive CKD and randomly assigned half to stop their blood pressure medication that works on the renin-angiotensin system (the same system losartan targets) and half to continue it. After three years, there was no meaningful difference in kidney function between the two groups. The group that stopped actually trended slightly worse, with an average eGFR of 12.6 compared to 13.3 in the group that continued. Stopping also did not improve quality of life or exercise capacity.
This trial largely settled the question: discontinuing losartan in advanced CKD does not rescue kidney function. The protective benefits of the drug, reducing protein leakage into urine, lowering pressure on damaged filtering units, and slowing scarring, continue to matter even when kidneys are severely impaired.
High Potassium: The Most Common Reason to Stop
Losartan can raise blood potassium levels because it affects how the kidneys handle this mineral. In healthy kidneys, this effect is minor. In CKD, where the kidneys already struggle to excrete potassium, losartan can push levels into a dangerous range. Potassium above 5.5 mmol/L is generally the threshold where doctors reassess, and levels above 6.0 mmol/L are a medical emergency because of the risk of heart rhythm problems.
This is why guidelines recommend checking both creatinine and potassium within 30 days of starting losartan or changing the dose. If potassium climbs too high, your doctor may try dietary changes or a potassium-lowering medication before pulling losartan entirely, since losing its kidney-protective effects is a real trade-off. But if potassium remains stubbornly elevated, stopping losartan becomes necessary.
Temporary Stops During Acute Illness
Some situations call for pausing losartan temporarily rather than stopping it permanently. During acute illness involving dehydration, vomiting, diarrhea, severe infection, or any condition that drops blood pressure or reduces fluid volume, losartan can worsen kidney function rapidly. The kidneys depend on a certain level of blood flow to function, and when that flow is already compromised by illness, losartan’s pressure-lowering effect on the kidney’s filtration system can tip things into acute kidney injury.
This concept is sometimes called “sick day rules.” If you’re unable to keep fluids down, running a high fever, or experiencing significant fluid losses, holding losartan until you recover is a reasonable precaution. Once the acute episode resolves and blood pressure stabilizes, the medication is typically restarted at the original dose, provided potassium is below 5 mmol/L and there’s no ongoing risk of dehydration.
Renal Artery Stenosis: A Hard Stop
One situation where losartan should be stopped and not restarted is bilateral renal artery stenosis, a condition where the arteries feeding both kidneys are significantly narrowed. In this scenario, the kidneys depend heavily on the pressure system that losartan blocks. Removing that pressure support can cause acute kidney failure.
This also applies to people with stenosis in a single functioning kidney. The same risk exists in patients with severe heart failure or profound sodium and volume depletion, where kidney blood flow is already precarious. If someone experiences a dramatic creatinine spike after starting losartan, renal artery stenosis is one of the first things doctors investigate. Once confirmed, losartan is permanently discontinued and alternative blood pressure medications are used.
What About Dialysis?
Once a patient starts dialysis, the decision to continue or stop losartan depends mainly on blood pressure control. The kidney-protective rationale becomes less relevant since the kidneys are no longer doing significant filtering work. Some dialysis patients continue losartan for blood pressure management or to protect any residual kidney function they still have. Losartan is generally tolerated in hemodialysis patients, though rare allergic-type reactions have been reported with certain dialysis membrane types. The decision at this stage is individualized based on blood pressure needs and how well the patient tolerates the medication.
Practical Thresholds to Know
- Creatinine rise over 30% after starting or increasing losartan: needs investigation and possible discontinuation
- Potassium above 5.5 mmol/L that doesn’t respond to other interventions: likely needs to stop
- Acute illness with dehydration or low blood pressure: temporarily hold losartan until recovery
- Bilateral renal artery stenosis: permanently stop
- Advanced CKD alone: not a reason to stop, based on trial evidence
The most important takeaway is that low eGFR by itself is not a reason to discontinue losartan. The situations that warrant stopping are specific and measurable: a dangerous potassium level, an excessive creatinine spike suggesting a vascular problem, or an acute illness that temporarily changes the risk-benefit balance. Outside those scenarios, the evidence favors continuing losartan through even the most advanced stages of kidney disease.